Abstract:We aimed to investigate the expression of microRNA-34a (miR-34a) in human gastric cancer cells and to evaluate the effects of miR-34a, acting via its gene survivin, on gastric cancer cell HGC-27 to provide potential new strategies for treating gastric cancer. In vitro cultures of the human gastric cancer cell lines MGC80-3, HGC-27, NCI-N87, and SGC-7901 and the normal human gastric epithelial cell line GES-1 were established. The expression of miR-34a in each gastric cancer cell line and GES-1 normal human gastric epithelial cell line was detected using quantitative real-time polymerase chain reaction (qRT-PCR). After the HGC-27 cells were transfected with a miR-34a mimic for 48 h, the changes in the expression levels of miR-34a were detected using qRT-PCR. The effect of miR-34a on HGC-27 cell viability was measured using a tetrazolium-based colorimetric [−(4,5)-dimethylthiahiazo-(−z-y1)-3,5-di-phenytetrazoliumromide (MTT)] assay. Flow cytometry was used to analyze the effects of miR-34a on HGC-27 cell proliferation. Annexin V/propidium iodide double staining and flow cytometry were used to analyze the effects of miR-34a on HGC-27 cell apoptosis. A Transwell invasion chamber was used to detect the effects of miR-34a on HGC-27 cell invasion. Finally, western blotting was used to analyze the effects of miR-34a on survivin protein expression. The qRT-PCR test determined that miR-34a expression in gastric cancer cells was significantly reduced compared to the normal gastric epithelial cell line GES-1 ( p < 0.01). Compared to the control group, cellular miR-34a expression levels were significantly increased in HGC-27 human gastric carcinoma cells after transfection with a miR-34a mimic for 48 h ( p < 0.01). The MTT assay demonstrated that after overexpressing miR-34a in HGC-27 cells, cellular viability was significantly reduced ( p < 0.05). Flow cytometry analysis determined that upon miR-34a overexpression, the proliferation index decreased significantly ( p < 0.05), and cellular apoptosis was significantly increased ( p < 0.01). The Transwell invasion chamber assay illustrated that after increasing the expression of miR-34a, the number of cells passing through the Transwell chamber was significantly reduced ( p < 0.01). Based on western blotting, compared with the control group, survivin protein expression levels were significantly decreased in the HGC-27 cells transfected with the miR-34a mimic for 48 h ( p < 0.01). In conclusion, the expression level of miR-34a was downregulated in human gastric cancer cell lines. miR-34a can negatively regulate survivin protein expression and inhibit gastric cancer cell proliferation and invasion. Therapeutically enhancing miR-34a expression or silencing the survivin gene may benefit patients with gastric cancer.

Additional File 3: Figure S3. of Mir-138-5p Contributes to Cell Proliferation and Invasion by Targeting Survivin in Bladder Cancer Cells

Mir-138-5p Contributes to Cell Proliferation and Invasion by Targeting Survivin in Bladder Cancer Cells

Effects of Survivin Mrna Expression on Apoptosis and Proliferation and MDR-1 in Hepatocellular Carcinoma

siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells.

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

[Construction of Mirna Expression Vector Dual-Targeting on HIF-1α/survivin Genes and Its Effects on Proliferation of Pancreatic Cancer Panc-1 Cell Line].

[Anti-Prostate Cancer Activity of Survivin-T34A Mutant in Vitro and in Vivo].

Expression of Mir-149-3p Inhibits Proliferation, Migration, and Invasion of Bladder Cancer by Targeting S100A4.

Tumor-suppressing Effect of Recombinant Adenovirus Encoding LRIG1 Gene Driven by Survivin Promoter in Nude Mice Heterotransplanted Models of Human Bladder Cancer

Study on the Correlation of the Effect of Microrna-218 Through Survivin on Cholangiocarcinoma Cells

Supplementary Figure S2 from Mir-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A

Mir-1-3p Contributes to Cell Proliferation and Invasion by Targeting Glutaminase in Bladder Cancer Cells

Study of Construction of Sirna Eukaryotic Expression Vector of Survivin Gene and Its Inhibitory Effect on Survivin Expression in Bladder Cancer Cells

Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells

Overexpressed Mir-301a Promotes Cell Proliferation and Invasion by Targeting Runx3 in Gastric Cancer

Mp88-16 targeted exosome-mediated delivery of survivin sirna for the treatment of bladder cancer

Expression of miR-1493 p inhibits proliferation , migration , and invasion of bladder cancer by targeting S 100 A 4

MiR-126 Regulates Proliferation and Invasion in the Bladder Cancer BLS Cell Line by Targeting the PIK3R2-mediated PI3K/Akt Signaling Pathway

Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299

Oncogene Mir-187-5p is Associated with Cellular Proliferation, Migration, Invasion, Apoptosis and an Increased Risk of Recurrence in Bladder Cancer.

Survivin Stable Knockdown by Sirna Inhibits Tumor Cell Growth and Angiogenesis in Breast and Cervical Cancers